These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6311016

  • 1. Evidence for adrenal and/or ovarian dysfunction as a possible etiology of idiopathic hirsutism.
    Bouallouche A, Brerault JL, Fiet J, Julien R, Vermeulen C, Cathelineau G.
    Am J Obstet Gynecol; 1983 Sep 01; 147(1):57-63. PubMed ID: 6311016
    [Abstract] [Full Text] [Related]

  • 2. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB, Ehrmann DA, Brigell DF, Rosenfield RL.
    J Clin Endocrinol Metab; 1993 Feb 01; 76(2):450-5. PubMed ID: 8381802
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Value of buserelin testing in the evaluation of hirsute women.
    Ambrosi B, Re T, Passini E, Bochicchio D, Ferrario R.
    J Endocrinol Invest; 1996 Apr 01; 19(4):204-9. PubMed ID: 8862498
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneity of late-onset adrenal 3 beta-ol-hydroxysteroid dehydrogenase deficiency in patients with hirsutism and polycystic ovaries.
    Morán C, Tena G, Herrera J, Bermúdez JA, Zárate A.
    Arch Med Res; 1994 Apr 01; 25(3):315-20. PubMed ID: 7803981
    [Abstract] [Full Text] [Related]

  • 7. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
    Toscano V, Balducci R, Bianchi P, Mangiantini A, Sciarra F.
    J Clin Endocrinol Metab; 1990 Aug 01; 71(2):288-92. PubMed ID: 2166066
    [Abstract] [Full Text] [Related]

  • 8. 11 beta-hydroxyandrostenedione: a marker of adrenal function in hirsutism.
    Hudson RW, Lochnan HA, Danby FW, Margesson LJ, Strang BK, Kimmett SM.
    Fertil Steril; 1990 Dec 01; 54(6):1065-71. PubMed ID: 2174005
    [Abstract] [Full Text] [Related]

  • 9. Evidence for reduced 3 beta-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome.
    Lobo RA, Goebelsmann U.
    J Clin Endocrinol Metab; 1981 Aug 01; 53(2):394-400. PubMed ID: 6265489
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue.
    Unluhizarci K, Gokce C, Atmaca H, Bayram F, Kelestimur F.
    Exp Clin Endocrinol Diabetes; 2004 Oct 01; 112(9):504-9. PubMed ID: 15505757
    [Abstract] [Full Text] [Related]

  • 12. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.
    Pang SY, Lerner AJ, Stoner E, Levine LS, Oberfield SE, Engel I, New MI.
    J Clin Endocrinol Metab; 1985 Mar 01; 60(3):428-39. PubMed ID: 2982896
    [Abstract] [Full Text] [Related]

  • 13. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
    Siegel SF, Finegold DN, Lanes R, Lee PA.
    N Engl J Med; 1990 Sep 27; 323(13):849-54. PubMed ID: 2168515
    [Abstract] [Full Text] [Related]

  • 14. Identification of virilizing adrenal tumors in hirsute women.
    Derksen J, Nagesser SK, Meinders AE, Haak HR, van de Velde CJ.
    N Engl J Med; 1994 Oct 13; 331(15):968-73. PubMed ID: 8084355
    [Abstract] [Full Text] [Related]

  • 15. Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women.
    Thompson DL, Horton N, Rittmaster RS.
    Clin Endocrinol (Oxf); 1990 Mar 13; 32(3):283-92. PubMed ID: 2160872
    [Abstract] [Full Text] [Related]

  • 16. Androsterone sulfate: physiology and clinical significance in hirsute women.
    Zwicker H, Rittmaster RS.
    J Clin Endocrinol Metab; 1993 Jan 13; 76(1):112-6. PubMed ID: 8380602
    [Abstract] [Full Text] [Related]

  • 17. Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17 alpha.
    Escobar-Morreale H, Pazos F, Potau N, García-Robles R, Sancho JM, Varela C.
    Fertil Steril; 1994 Sep 13; 62(3):521-30. PubMed ID: 8062947
    [Abstract] [Full Text] [Related]

  • 18. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F, Hatala DA, Speroff L.
    Am J Obstet Gynecol; 1991 Sep 13; 165(3):535-45. PubMed ID: 1832519
    [Abstract] [Full Text] [Related]

  • 19. Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism.
    Rossi R, Tauchmanovà L, Luciano A, Valentino R, Savastano S, Battista C, Di Martino M, Lombardi G.
    J Endocrinol Invest; 2001 Sep 13; 24(7):491-8. PubMed ID: 11508782
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.